Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.
Ajeganova S, Andersson MLE, Frostegård J, Hafström I.
Arthritis Res Ther. 2021 Jul 27;23(1):201. doi: 10.1186/s13075-021-02581-0.
PMID: 34311770